- 6-12 months initial stabilization
- 3-6 months to achieve disease control
- 75%
China versus the U.S.
- China clinical rate
- $1,000 – $5,000
- $3,000
- United States
- $4,000 – $20,000
- $12,000
- You save
- ~75%
- $9,000 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Multidisciplinary systemic lupus erythematosus management utilizing immunosuppressants, biologics, and organ-specific interventions. China has extensive clinical experience treating lupus given its higher prevalence in Asian populations. Leading centers like Peking Union Medical College Hospital offer cutting-edge treatments including belimumab and novel targeted therapies.
Step by step.
Disease Activity Assessment
Complete lupus workup including ANA panel, complement levels, organ function tests, and SLEDAI scoring
Immunosuppressive Protocol
Tailored immunosuppression with hydroxychloroquine, mycophenolate, or cyclophosphamide based on organ involvement
Biologic Addition
Consider belimumab or anifrolumab for refractory cases or to reduce steroid dependence
Long-term Monitoring
Regular flare monitoring, organ protection strategies, and medication tapering protocols
- High clinical expertise due to large lupus patient population in China
- Access to novel Chinese-developed lupus biologics
- Integrated nephrology and dermatology support
- Significantly lower medication and monitoring costs
- Serious infection risk from immunosuppression
- Potential organ damage if undertreated
- Medication side effects including bone loss and metabolic changes
- Disease flares during treatment adjustments
Ask the AI for hospitals that handle lupus (sle) treatment.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.